NDC11 50881002801
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 50881-0028-01 | 50881-0028 |
| 50881-0028-1 | 50881-0028 |
| 50881-028-01 | 50881-028 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PEMAZYRE | PEMIGATINIB | Incyte Corporation | 9e1f2222-1d89-4e63-989c-ccebe2ab1eb4 | 2026-06-09 | Warnings, Adverse reactions | 50881-028-01 50881-028 50881002801 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.